Standardized patient coaching improves therapy persistence in patients with hormone receptor-positive, HER2-negative advanced/metastatic breast cancer treated with abemaciclib.
- DOI
- 10.1016/j.breast.2025.104684
- Published
- 2026 Feb
- Container
- Breast (Edinburgh, Scotland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2025.104684,
title = {Standardized patient coaching improves therapy persistence in patients with hormone receptor-positive, HER2-negative advanced/metastatic breast cancer treated with abemaciclib.},
author = {Welslau M and Fasching PA and Semmler-Lins N and Mueller L and Belleville E and Rieger L and Uhrig S and Zahn MO and Lex B and Uleer C and Deuerling N and Hesse T and Langanke D and Häberle L and Tesch H},
year = {2026},
journal = {Breast (Edinburgh, Scotland)},
doi = {10.1016/j.breast.2025.104684},
url = {https://doi.org/10.1016/j.breast.2025.104684}
}RIS
TY - JOUR TI - Standardized patient coaching improves therapy persistence in patients with hormone receptor-positive, HER2-negative advanced/metastatic breast cancer treated with abemaciclib. AU - Welslau M AU - Fasching PA AU - Semmler-Lins N AU - Mueller L AU - Belleville E AU - Rieger L AU - Uhrig S AU - Zahn MO AU - Lex B AU - Uleer C AU - Deuerling N AU - Hesse T AU - Langanke D AU - Häberle L AU - Tesch H PY - 2026 JO - Breast (Edinburgh, Scotland) DO - 10.1016/j.breast.2025.104684 UR - https://doi.org/10.1016/j.breast.2025.104684 ER -
APA
M, W., PA, F., N, S., L, M., E, B., L, R., S, U., MO, Z., B, L., C, U., N, D., T, H., D, L., L, H., & H, T. (2026). Standardized patient coaching improves therapy persistence in patients with hormone receptor-positive, HER2-negative advanced/metastatic breast cancer treated with abemaciclib.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2025.104684
Source records
- pubmed · retrieved 2026-09-25T08:17:56.142Z